EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism

Kang-Xi Zhang, Yue Zhu, Shu-Xia Song, Qing-Yun Bu, Xiao-Yan You, Hong Zou, Guo-Ping Zhao

Molecules · 01.03.2024 · 29 (5) · 1108

DOI: 10.3390/molecules29051108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 01.03.2024. Verfasst von Kang-Xi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Henan Engineering Research Center of Food Microbiology, College of Food and Bioengineering, Henan University of Science and Technology, Luoyang 47102…. Hauptthemen laut MEDLINE: Ginsenosides, Gastrointestinal Microbiome, Hyperlipidemias, Sapogenins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Synthetic Biotechnology Innovation Capacity Improvement Projects, Major Project of Haihe Laboratory of Synthetic Biology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperlipidemia, characterized by elevated serum lipid concentrations resulting from lipid metabolism dysfunction, represents a prevalent global health concern. Ginsenoside Rb1, compound K (CK), and 20(S)-protopanaxadiol (PPD), bioactive constituents derived from Panax ginseng, have shown promise in mitigating lipid metabolism disorders. However, the comparative efficacy and underlying mechanisms of these compounds in hyperlipidemia prevention remain inadequately explored. This study investigates the impact of ginsenoside Rb1, CK, and PPD supplementation on hyperlipidemia in rats induced by a high-fat diet. Our findings demonstrate that ginsenoside Rb1 significantly decreased body weight and body weight gain, ameliorated hepatic steatosis, and improved dyslipidemia in HFD-fed rats, outperforming CK and PPD. Moreover, ginsenoside Rb1, CK, and PPD distinctly modified gut microbiota composition and function. Ginsenoside Rb1 increased the relative abundance of Blautia and Eubacterium, while PPD elevated Akkermansia levels. Both CK and PPD increased Prevotella and Bacteroides, whereas Clostridium-sensu-stricto and Lactobacillus were reduced following treatment with all three compounds. Notably, only ginsenoside Rb1 enhanced lipid metabolism by modulating the PPARγ/ACC/FAS signaling pathway and promoting fatty acid β-oxidation. Additionally, all three ginsenosides markedly improved bile acid enterohepatic circulation via the FXR/CYP7A1 pathway, reducing hepatic and serum total bile acids and modulating bile acid pool composition by decreasing primary/unconjugated bile acids (CA, CDCA, and β-MCA) and increasing conjugated bile acids (TCDCA, GCDCA, GDCA, and TUDCA), correlated with gut microbiota changes. In conclusion, our results suggest that ginsenoside Rb1, CK, and PPD supplementation offer promising prebiotic interventions for managing HFD-induced hyperlipidemia in rats, with ginsenoside Rb1 demonstrating superior efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesGastrointestinal MicrobiomeHyperlipidemiasSapogeninsRatsAnimalsDiet, High-FatLipid MetabolismBody WeightBile Acids and Salts

Stichwörter der Autor:innen

bile acid metabolismginsenoside CKginsenoside PPDginsenoside Rb1gut microbiotahyperlipidemia

Substanzen

GinsenosidesBile Acids and SaltsSapogeninsginsenoside Rb1ginsenoside compound Kprotopanaxadiol

Autor:innen und Institutionen

  • Henan Engineering Research Center of Food Microbiology, College of Food and Bioengineering, Henan University of Science and Technology, Luoyang 471023, China.
  • Master Lab for Innovative Application of Nature Products, National Center of Technology Innovation for Synthetic Biology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
  • Haihe Laboratory of Synthetic Biology, Tianjin 300308, China.
  • CAS Engineering Laboratory for Nutrition, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
  • CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China.

Förderung

  • Tianjin Synthetic Biotechnology Innovation Capacity Improvement Projects
  • Major Project of Haihe Laboratory of Synthetic Biology

Zitieren

APA

Zhang, K. X., Zhu, Y., Song, S. X., Bu, Q. Y., You, X. Y., Zou, H., & Zhao, G. P. (2024). Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules, 29(5), 1108. https://doi.org/10.3390/molecules29051108

Vancouver

Zhang KX, Zhu Y, Song SX, Bu QY, You XY, Zou H, et al. Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules. 2024;29(5):1108. doi:10.3390/molecules29051108

BibTeX
@article{Zhang2024,
  author = {Zhang, Kang-Xi and Zhu, Yue and Song, Shu-Xia and Bu, Qing-Yun and You, Xiao-Yan and Zou, Hong and Zhao, Guo-Ping},
  title = {Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {5},
  pages = {1108},
  doi = {10.3390/molecules29051108}
}
Kostenlos starten →